HIGHLIGHTS
- who: Marco Capecchi and colleagues from the Division of Hematology, Clinica Moncucco, Lugano, Switzerland have published the article: Anticoagulant Therapy in Patients with Antiphospholipid Syndrome, in the Journal: (JOURNAL)
- what: In this A summary of the recommendations management antithrombotic specific scenario, monitoring of anti-factorfor Xathe activity may be of helpful to titer theprophyoptimal laxis anddose treatment in patients with APS reported in Figure 2. effect to prevent recurrent heparin with the aim of reaching theisdesired anticoagulant thrombosis and minimize the risk of bleeding. The RAPS (Rivaroxaban in AntiPhospholipid Syndrome) study was the first randomized . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.